Description

Cannabis Variety Pack – Product Information

• The Cannabis Variety Pack consists of 2 x 25mg Delta 9 THC Gummies, 2x 25mg Delta 8 THC Gummies, 2 x 25mg Delta 10 THC Gummies, 2 x 25mg Delta THC O-Acetate Gummies, and 2 x 25mg HHC Gummies.
• This Cannabis Variety Pack includes a total of 10 x 25mg gummies, amounting to 250mg in total.

What is the Cannabis Variety Pack?

The Cannabis Variety Pack consists of 2 of each of our 25mg gummy variants across our store, offering a unique glimpse into the following compounds:

Delta-8 THC: Formed through the degradation of delta-9 THC over time, delta-8 THC occurs in minimal amounts in cannabis plants but can be concentrated for research purposes. It interacts with the endocannabinoid system, potentially offering therapeutic benefits such as pain relief and anxiety reduction, albeit with a milder psychoactive effect compared to delta-9 THC.

Delta 10 THC: Discovered in the 1980s, delta-10 THC is found in trace amounts in cannabis plants and is chemically derived from the hemp plant. It’s reported to be a degradation product and may exist as an impurity in delta-8 THC derived from cannabidiol (CBD).

Delta-9 THC: A natural compound in cannabis and hemp plants, delta-9 THC is known for its psychoactive effects. It interacts with cannabinoid receptors, leading to potential physiological and psychological effects, including relaxation, euphoria, altered perception of time, increased appetite, and sensory changes.

THC-O Acetate: Derived from hemp, THC-O acetate is a tetrahydrocannabinol derivative produced in a laboratory. Recognized for its potential appetite-stimulating, anti-anxiety, and anti-nausea qualities, THC-O acetate gained attention from research studies dating back to experiments conducted by the U.S. military in 1949.

HHC (Hexahydrocannabinol): A hemp-derived cannabinoid, HHC is a naturally occurring compound found in trace concentrations in hemp plants. Transformed from hemp-derived CBD and THC into synthetic HHC, this cannabinoid adds to the complexity of our Cannabis Variety Pack, providing an intriguing avenue for research exploration.

Our variety pack combines each of these distinctive potential properties to provide a comprehensive view of the vast landscape of cannabis derivatives.

How does it work?

Delta-8 THC

Delta-8 THC has the potential to engage with the endocannabinoid system (ECS) by attaching to the CB1 receptors predominantly located in the brain and central nervous system. The ECS plays a pivotal role in overseeing various physiological processes such as appetite, mood, pain sensation, and immune function.

Despite sharing a similar chemical composition with delta-9 THC, the primary psychoactive compound in marijuana, Delta-8 THC exhibits some differences in molecular structures, leading to distinct potential effects.

Research indicates that Delta-8 THC generates less potentially potent psychoactive effects than Delta-9 THC. This could be attributed to its lower affinity for CB1 receptors and its ability to bind to other receptors in the ECS. Furthermore, Delta-8 THC might have the potential to impact appetite, pain relief, and nausea differently compared to Delta-9 THC.

In summary, the mechanisms of action of Delta-8 THC are still under investigation, and further research is imperative to comprehensively understand its interactions.

Delta 10 THC

While limited research has explored the impact of Delta 10 THC, it is hypothesized to have the potential to influence the CB receptors. The body harbors two types of CB receptors – CB1 and CB2 – with CB1 reportedly residing in the brain. [R]

Studies indicate that CB1 receptors surpass many other receptors in the brain. These receptors are identified as regulators of various neurotransmitters, affording them the capability to govern hunger, temperature, and alertness.[R]

Delta-9 THC

Delta 9 THC possesses the potential to engage with the intricate endocannabinoid system (ECS), a network comprising receptors, enzymes, and endocannabinoids that contribute to the regulation of diverse physiological processes, aiming to maintain balance. When administered to research subjects, Delta 9 THC binds to cannabinoid receptors, notably CB1 receptors predominantly located in the brain. This binding initiates a cascade of biochemical reactions, resulting in varied effects.

Specifically, Delta 9 THC emulates the actions of the endocannabinoid anandamide, a naturally occurring compound. Through binding to CB1 receptors, Delta 9 THC can influence the release of neurotransmitters, impacting signal transmission in the brain.

The modulation of neurotransmitters, including dopamine and serotonin, gives rise to the psychoactive effects linked with Delta 9 THC. The activation of CB1 receptors in different brain regions has the potential to affect mood, memory, appetite, pain perception, and other cognitive functions.

It’s important to acknowledge that the mechanism of action of Delta 9 THC is intricate, and ongoing research is uncovering the comprehensive impact on the bodies and brains of research subjects. [R]

THC-O Acetate

THC-O Acetate is a synthetic cannabinoid derived from Delta-9 THC, the primary psychoactive compound found in cannabis. The “O Acetate” designation indicates the presence of an acetate group, a modification typically introduced in a laboratory setting. The acetate modification is believed to enhance the compound’s stability and increase its bioavailability. Upon potentially binding to CB1 receptors, THC-O Acetate may induce psychoactive effects, akin to Delta-9 THC. However, the unique chemical structure of THC-O Acetate may result in distinct psychoactive properties and potential therapeutic effects.

HHC (Hexahydrocannabinol)

Given the striking resemblance in their chemical structures, THC and HHC both have the potential to engage with the CB1 and CB2 receptors within the endocannabinoid system.

All mammals possess an intrinsic modulation system known as the endocannabinoid system, governing crucial processes such as sleep, memory, pain, immune responses, appetite, mood, and various other physiological functions.

Cannabinoids like THC, CBD, and HHC, originating from cannabis, have the potential to act as molecular keys fitting into these receptor locks, initiating potential biological responses.

The key differentiator lies in the potency of HHC compared to THC, with THC recognized as a more robust cannabinoid. Despite its lower potency, HHC still elicits psychoactive effects.

Potential Research Applications:

Pain Relief

Delta-8 THC exhibits analgesic properties as evidenced in laboratory studies. Research published in the Journal of Pain Research revealed that delta-8 THC decreased pain and inflammation in mice with corneal injury. Additionally, a study in Cannabis and Cannabinoid Research demonstrated that delta-8 THC alleviated pain in rats with chronic neuropathic pain. [R]

Preclinical studies have suggested that Delta 9 THC may have analgesic properties and can help alleviate pain and physical discomfort. For example, a study published in the European Journal of Pharmacology found that Delta 9 THC effectively reduced pain sensitivity in mice. [R]

A recent preclinical study that was conducted on rats suggests that HHC may have potential analgesic effects [R].

Anxiety Reduction

The anxiolytic effects of Delta 8 THC are suggested by a study in Pharmacology Biochemistry and Behavior. This study observed a reduction in anxiety-like behavior in mice treated with delta-8 THC, indicating its potential as a treatment for anxiety disorders. [R]

Nausea and Vomiting Relief

Clinical studies support the antiemetic properties of Delta-8 THC. A study published in the British Journal of Pharmacology found that delta-8 THC reduced nausea and vomiting in children undergoing chemotherapy. Another research demonstrated the efficacy of delta-8 THC in reducing vomiting in shrews. [R]

Anti-Inflammatory Effects

Delta 9 THC has demonstrated potential as an anti-inflammatory agent, as highlighted in a study published in the Journal of Neuroimmune Pharmacology. This study observed that Delta 9 THC reduced inflammation and ameliorated symptoms in a mouse model of multiple sclerosis. [R]

Potential for Muscle Relaxation

Delta 9 THC has shown muscle relaxant properties in certain studies. For instance, a study published in the European Journal of Pharmacology found that Delta 9 THC reduced muscle spasms in a rat model of dystonia. [R]

The effects of Delta O Acetate were originally studied in 1949 by the US military as part of a broader experiment known as the Edgewood Arsenal Experiments. The military discovered that Delta O Acetate was prevalent and affected muscle coordination in dogs twice as much as commonly found in Delta 9 THC. [R]

Potential to Improve Relaxation & Mood

HHC is recognized as a potential psychotropic compound, given its ability to potentially activate the same CB1 receptors in the brain that induce euphoria and alter perceptions. The key distinction from delta-9 THC is that HHC may offer more of a sense of relaxation, akin to the potential effects observed in delta-8.

Frequently Asked Questions

What is the Cannabis Variety Pack?

The Cannabis Variety Pack is an assortment of research-focused gummies, each containing 25mg of different cannabinoids. Designed for scientific exploration, this pack includes Delta-8 THC, Delta-10 THC, Delta-9 THC, THC-O Acetate, and HHC (Hexahydrocannabinol), offering a diverse view of cannabinoids for research purposes.

Are these products legal?

Yes, these products are legal for research purposes. It’s crucial to adhere to local regulations regarding the use and possession of research compounds.

How should I store the Cannabis Variety Pack?

Store the Cannabis Variety Pack in a cool, dry place away from direct sunlight to maintain the quality of the compounds. Ensure the pack is sealed properly to prevent any contamination.

Summary

Our Cannabis Variety Pack stands as a key element to understanding the diverse effects of cannabinoids. From Delta-8 THC’s nuanced psychoactive impact to Delta-9 THC’s well-known psychoactivity and the potential therapeutic benefits of THC-O Acetate and HHC, each compound contributes to the intricate tapestry of cannabis derivatives.

As researchers delve into the mechanisms of action, the potential applications become apparent. Pain relief, anxiety reduction, nausea relief, anti-inflammatory effects, muscle relaxation, and mood enhancement are promising areas of exploration. The Cannabis Variety Pack offers a unique opportunity to investigate these compounds in a controlled and rigorous research setting.

Disclaimer

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners.

By using PureRawz Delta and CBD compounds, you agree to the Privacy Policy and all Terms and Conditions listed on this website. All CBD & Delta products displayed for sale at PureRawz.com are sourced from industrial hemp plants which contain less than 0.3% THC and are federally legal. PureRawz is not responsible for any legal charges that may come as a result of local or State laws. It is the buyer’s responsibility to determine if any transaction with PureRawz violates local regulations or laws.

All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human usage. The Federal Food, Drug, and Cosmetic Act requires this notice.

By completing and paying for your order, you agree to our Terms and Conditions. Customer satisfaction is our number one priority – if you are not 100% satisfied with the product you received, please contact us at support@purerawz.co